About EbiCap
Evidence-Based Investing · Capital
EbiCap is a pharmaceutical accountability platform. We measure whether the capital pharmaceutical companies extract from patients, payers, and public research systems is proportional to the clinical value they deliver to society.
Our Mission
The pharmaceutical industry operates with significant information asymmetries. Clinical trial results are selectively published. Pricing decisions are opaque. Executive compensation is structured around revenue metrics that are decoupled from patient outcomes. Health technology assessment verdicts — the most rigorous independent evaluation of clinical benefit — are scattered across dozens of national agencies in multiple languages.
EbiCap unifies, structures, and scores this information at the company level — so that investors, policy researchers, journalists, and health professionals can make evidence-based judgements without requiring access to proprietary data services.
Operating Principles
⬡
Public Data Only
Every metric in EbiCap is derived from publicly available regulatory, clinical, financial, and health authority data. No proprietary estimates. No black-box models.
⬡
Reproducible Methodology
Our TI Score, Neglect Index, and VCSi classification are fully documented. Any academic institution can replicate our outputs from the same source data.
⬡
No Issuer Relationships
EbiCap accepts no advertising, sponsorship, or data licensing revenue from pharmaceutical companies. Our analysis is structurally independent.
⬡
Evidence Over Narrative
We do not editorialize. Clinical verdicts, HTA benefit ratings, and compensation structures are presented as structured data — conclusions are yours to draw.
Data Sources
EbiCap currently integrates 15+ public data sources including ClinicalTrials.gov, SEC EDGAR, EMA Medicines Registry, FDA Orange/Purple Book, WHO Global Burden of Disease registries, HTA agency outputs from NICE, G-BA, HAS, PBAC, SMC and others, NIH iCite citations, and DOJ / Violation Tracker enforcement records.
Read the full methodology →Contact
For access requests, data questions, or media enquiries, visit our contact page or request a demo.